Riskpilot← Back to searchSign inGet full accessTerumo Sweden AB
ABActiveOrg 5566351176Sven Källfelts Gata 18 Byggnad 90Wholesale of pharmaceutical and medical goods · NACE 4646Est. 200230 employees
Revenue 2025
SEK 265,2M
0% vs 2024
EBITDA margin
3.9%
-7% vs 2024
Equity ratio
26.7%
Financial strength
Net profit 2025
SEK 8,9M
-10% vs 2024
| Revenue | SEK 265,2M | +0% |
| EBITDA | SEK 10,4M | -7% |
| Net profit | SEK 8,9M | -10% |
| Total assets | SEK 41,6M | -6% |
| Equity | SEK 11,1M | -6% |
| Employees | 30 | — |
Legal name
Terumo Sweden AB
Org number
5566351176
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
12 november 2002
Share capital
SEK 100 000
Employees
30 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall, ensamt eller i samverkan med annan, försälja medicinska och andra termometrar, nålar och sprutor, kärl och övrig utrustning för blodprovstagning. Bolaget skall härutöver jämväl försälja annan medicinsk teknisk utrustning innefattande bland annat kemisk, vetenskaplig, elektrisk och elektronisk utrustning samt olika former av glasprodukter tillverkade av gummi eller plast. Bolaget skall också tillhandahålla rådgivning till köparna samt syssla med försäljning, import från och export till återförsäljare, distributörer och sälja produkterna på kommission.
Address
Sven Källfelts Gata 18 Byggnad 90
Email
terumo.nordic@terumo-europe.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 240 896 | 239 160 | 250 919 | 265 616 | 265 195 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 8 529 | 7 247 | 9 526 | 11 269 | 10 430 |
| Depreciation & amort. | −0 | −10 | −11 | −24 | −11 |
| EBIT | 8 529 | 7 237 | 9 515 | 11 245 | 10 419 |
| Net financials | — | 67 | 602 | 1 376 | 1 281 |
| Profit before tax | 8 528 | 7 313 | 10 118 | 12 635 | 11 701 |
| Tax | −1 852 | −1 537 | −2 174 | −2 786 | −2 835 |
| Net profit | 6 676 | 5 776 | 7 944 | 9 849 | 8 866 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 30 308 | 36 905 | 41 074 | 44 153 | 41 620 |
| Equity | 8 443 | 7 669 | 9 615 | 11 876 | 11 128 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 21 865 | 29 236 | 31 459 | 32 277 | 30 492 |
| Total debt | 21 865 | 29 236 | 31 459 | 32 277 | 30 492 |
EBITDA margin
3.9%
This company
15.8%
Market median
-75% vs market
20212025
Equity ratio
26.7%
This company
38.2%
Market median
-30% vs market
20212025
Return on equity
79.7%
This company
18.4%
Market median
+333% vs market
20212025
Net profit margin
3.3%
This company
8.1%
Market median
-59% vs market
20212025
Asset turnover
6.37×
This company
1.12×
Market median
+469% vs market
20212025
Debt / equity
2.74×
This company
0.62×
Market median
-342% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AO Chief Auditor | Chief Auditor | 2023 |
| Former (1) | ||
MA Chief Auditor | Chief Auditor | 2020 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Former (3) | ||
| Chairman | 2020 – 2023 | |
| Chairman | 2020 – 2022 | |
| Board of Directors | 2020 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
TERUMO EUROPE NV
Terumo Sweden AB (this company)Board members of Terumo Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marina Ann Elizabeth Pääkkö | Chief Auditor | 0 companies |
| Anders Oskar Erik Dahnér | Chief Auditor | 0 companies |
| Norimasa Kunimoto | Chairman | 0 companies |
| Takuya Hosokai | Chairman | 0 companies |
| Peter Donald Coenen | Chairman | 0 companies |
| Sebastian Alexander Jeroom Marie Corneel Vanloot | Board of Directors | 0 companies |
| Monica Ulrika Haag | Board of Directors | 0 companies |
| Bhawna Menghnani | Board of Directors | 0 companies |